Rachael A Safyan

4PUBLICATIONS
36CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001.

Elena Gabriela Chiorean, Sheela R Damle, David B Zhen

|Dec 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Amy H Huang, Gin Yi Lee, Chuan Angel Lu

|Jun 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Gentry G King, Kelsey K Baker, Andrew L Coveler

|Dec 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

Naomi Yamamoto, Stephanie Dobersch, Ian Loveless

Pageof 1

Frequent Collaborators

4 joint publications

Elena Gabriela Chiorean

3 joint publications

David B Zhen

3 joint publications

Andrew L Coveler

1 joint publications

Sheela R Damle